Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article published on 21 April 2017 |
| Author/s |
author: Keiichi Fujiwara Karen Basen-Engquist Byoung Gie Kim |
| Publication date | April 21, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |